TSPAN5 and hepatocellular carcinoma: It is therefore conceivable that a defect in exosome biosynthesis, nuclear content loading and SASP factor secretion contributes to the anti-tumor effects of TSPAN5 silencing observed in CAM tumors and HCC xenografts.